General Information
Revision date
2006-10-30
Product name
Ondansetron Injection, USP Hydrochloride Products include the following
Product Synonyms
1,2,3,9-Tetrahydro-90methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one hydrochloride
Manufacturer Name
Hospira, Inc
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
Hospira, Inc
Section 2
SECTION 2: Hazards identification
Ingredient Name Ondansetron Hydrochloride Dihydrate Chemical Formula C18H19N3O * HCL * 2H2O Component Approximate Percent CAS Number RTECS Number by Weight Ondansetron Hydrochloride <0.20% 103639-04-9 FE6375500 Dihydrate SDV Non-hazardous ingredients include: Water, and NaCl, and Citric Acid. MDV Non-hazardous ingredients include: Water, NaCl, Citric Acid, Methyl Paraben, Propyl Paraben Premix in 5% Dextrose Non-hazardous ingredients include: Water, Dextrose, Citric Acid and Sodium Citrate 3. HAZARD INFORMATION Emergency Overview Caution – Potent pharmaceutical agent. Health effects information is based on hazards of components. Occupational Exposure Handling this product in its final form presents minimal risk from occupational Potential exposure. Signs and Symptoms Possible effects of overexposure in the workplace include: symptoms of hypersensitivity (such as skin rash, hives, itching, and difficulty breathing); headache; constipation; flushing; abnormal nervous system sensations. Medical Conditions Aggravated Hypersensitivity to material and impaired liver function. by Exposure 1